The TRA @ P-TIMI @ ( Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis In Myocardial Infarction @ ) was a randomized , double-blind , placebo-controlled trial of vorapaxar @ mg daily in @,@ patients with atherosclerosis , stratified by qualifying disease ( MI , PAD , or CVD ) .